Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

MLA

Josée Guindon, and Andrea G. Hohmann. “Cannabinoid CB2 Receptors: A Therapeutic Target for the Treatment of Inflammatory and Neuropathic Pain.” British Journal of Pharmacology, vol. 153, Jan. 2008, pp. 319–34. EBSCOhost, https://doi.org/10.1038/sj.bjp.0707531.

APA

Josée Guindon, & Andrea G. Hohmann. (2008). Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. British Journal of Pharmacology, 153, 319–334. https://doi.org/10.1038/sj.bjp.0707531

Chicago

Josée Guindon, and Andrea G. Hohmann. 2008. “Cannabinoid CB2 Receptors: A Therapeutic Target for the Treatment of Inflammatory and Neuropathic Pain.” British Journal of Pharmacology 153 (January): 319–34. doi:10.1038/sj.bjp.0707531.